WPD-401

N/A

Report date: 2024/06/20 12:05:19

Base Information

Drug NameWPD-401
Drug Alias NameInterceptor (WPD Pharmaceuticals)Meteor (WPD Pharmaceuticals)WPD401WPD-401WPD402 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-13 receptor subunit alpha-2 modulatorsEphrin type-A receptor 2 antagonistsEphrin type-A receptor 3 inhibitors +[4] 
TargetsInterleukin-13 receptor subunit alpha-2Ephrin type-A receptor 2Ephrin type-A receptor 3 +[4] 
Therapy Area/IndicationsBreast NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWPD Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesWPD Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A